Paragon Associates & Paragon Associates II Joint Venture

In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 13, 2024), Paragon Associates & Paragon Associates II Joint Venture reported 11 stock positions worth $40.9 million. Its top holding was Navigator (NVGS) at 25.6% of the portfolio, followed by Agnico Eagle Mines (AEM, 14.4%) and Newmont (NEM, 11.8%). Compared with Q1 2024, it opened 1 new position, sold out of 6, added to 2 and reduced 5. The biggest buy was Newmont (NEM, shares +130%) and the biggest sale an exit from PBF Energy Class A (PBF).

Most Recent 13F
Q1 2026
Location
DALLAS, TX
CIK
0001047859
Portfolio Value
$40.9M (Q2 2024)
SEC Filing
0001047859-24-000003 ↗ filed Aug 13, 2024

Holdings Value

0$20.0M$40.0M$60.0M$80.0M Q1 2024: $56.1M Q1 2024 Q2 2024: $40.9M $40.9M Q2 2024 Q3 2024: $55.7M Q3 2024 Q4 2024: $43.2M Q4 2024 Q1 2025: $42.7M Q1 2025 Q2 2025: $63.0M Q2 2025 Q3 2025: $56.1M Q3 2025 Q4 2025: $48.4M Q4 2025 Q1 2026: $73.6M Q1 2026

Holdings 11 stocks · $40.9M

NVGS Navigator Holdings Ltd. 25.62% 600,000 $10.5M Reduce -14.3%
AEM Agnico Eagle Mines Ltd. 14.40% 90,000 $5.9M Reduce -40.0%
NEM Newmont Corp. 11.78% 115,000 $4.8M Add +130.0%
EPSN Epsilon Energy Ltd. 10.66% 800,000 $4.4M No change
BELFB Bel Fuse Inc. Class B 9.10% 57,000 $3.7M Reduce -5.0%
FNV Franco-Nevada Corp. 8.70% 30,000 $3.6M Add +20.0%
IRIX Iridex Corp. 5.28% 1,000,000 $2.2M No change
ECVT Ecovyst Inc. 5.27% 240,200 $2.2M Reduce -20.0%
ALSN Allison Transmission Holding 3.71% 20,000 $1.5M No change
DMAC Diamedica Therapeutics Inc. 3.48% 482,614 $1.4M Reduce -3.5%
AKYA Akoya Biosciences Inc. 2.00% 350,000 $819K New

Portfolio Sells Q1 2024 → Q2 2024

PBF PBF Energy Inc. Class A Sold out 0.00% −7.70
VLO Valero Energy Corp. Sold out 0.00% −7.61
UBS UBS Group AG-Reg Sold out 0.00% −4.11
BP BP PLC-Spons ADR Sold out 0.00% −3.36
HUM Humana Inc. Sold out 0.00% −2.47
AEM Agnico Eagle Mines Ltd. Reduce -40.0% 14.40% −1.56
ECVT Ecovyst Inc. Reduce -20.0% 5.27% −0.70
GEL Genesis Energy L.P. Sold out 0.00% −0.20
DMAC Diamedica Therapeutics Inc. Reduce -3.5% 3.48% +1.01
BELFB Bel Fuse Inc. Class B Reduce -5.0% 9.10% +2.64
NVGS Navigator Holdings Ltd. Reduce -14.3% 25.62% +6.46

Portfolio Buys Q1 2024 → Q2 2024

NEM Newmont Corp. Add +130.0% 11.78% +8.58
FNV Franco-Nevada Corp. Add +20.0% 8.70% +3.38
AKYA Akoya Biosciences Inc. New 2.00% +2.00

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q1 2026 14$73.6MCDE, SPY, CDNA, DMAC, NVGS
Q4 2025 12$48.4MAEM, CDNA, DMAC, QQQ, NVGS
Q3 2025 12$56.1MAEM, NVGS, CDNA, DMAC, AMG
Q2 2025 15$63.0MAEM, NVGS, SPY, EPSN, STKL
Q1 2025 13$42.7MAEM, NVGS, EPSN, BELFB, NPKI
Q4 2024 12$43.2MAEM, NVGS, BELFB, EPSN, FNV
Q3 2024 16$55.7MNVGS, AEM, SPY, BELFB, EPSN
Q2 2024 11$40.9MNVGS, AEM, NEM, EPSN, BELFB
Q1 2024 16$56.1MNVGS, AEM, EPSN, PBF, VLO